Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.75 | -$0.75 | -$0.75 |
| Q2 2025 | 1 | -$1.50 | -$1.50 | -$1.50 |
| Q3 2025 | 1 | -$1.50 | -$1.50 | -$1.50 |
Celularity Inc. last posted its earnings results on Friday, November 14th, 2025. The company reported $-0.87571 earnings per share for the quarter, topping analysts' consensus estimates of $-1.5 by $0.62429. The company had revenue of 5.28 M for the quarter and had revenue of 54.22 M for the year. Celularity Inc. has generated $-3 earnings per share over the last year ($-2.6446 diluted earnings per share) and currently has a price-to-earnings ratio of -0.62. Celularity Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 14th, 2025 based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2025 | Q3 2025 | -$1.50 | -$0.88 | 0.62 | $5.28 M | $5.28 M |
| 08/29/2025 | Q2 2025 | N/A | -$1.02 | N/A | $5.74 M | $5.74 M |
| 08/29/2025 | Q1 2025 | N/A | -$0.84 | N/A | N/A | $11.43 M |
| 05/08/2025 | Q4 2024 | N/A | -$0.59 | N/A | N/A | $18.13 M |
| 12/05/2024 | Q3 2024 | N/A | -$0.73 | N/A | $5.30 M | $9.30 M |
| 11/06/2024 | Q2 2024 | N/A | -$0.30 | N/A | $4.80 M | $12.11 M |
| 10/16/2024 | Q1 2024 | N/A | -$1.03 | N/A | N/A | $14.68 M |
| 07/30/2024 | Q4 2023 | N/A | $0.49 | N/A | N/A | $12.11 M |
| 01/02/2024 | Q3 2023 | N/A | -$4.99 | N/A | $27.22 M | $3.79 M |
| 08/14/2023 | Q2 2023 | N/A | -$2.72 | N/A | N/A | $2.94 M |
| 05/22/2023 | Q1 2023 | N/A | -$4.12 | N/A | N/A | $3.94 M |
| 03/31/2023 | Q4 2022 | N/A | $1.64 | N/A | N/A | $4.13 M |
| 11/10/2022 | Q3 2022 | N/A | $0.34 | N/A | N/A | $4.14 M |
| 08/09/2022 | Q2 2022 | N/A | $3.41 | N/A | N/A | $3.78 M |
| 05/16/2022 | Q1 2022 | N/A | -$4.82 | N/A | N/A | $5.94 M |
| 03/31/2022 | Q4 2021 | N/A | -$0.33 | N/A | N/A | $4.86 M |
| 11/12/2021 | Q3 2021 | N/A | $4.69 | N/A | N/A | $10.62 M |
| 08/18/2021 | Q2 2021 | N/A | -$26.87 | N/A | N/A | $3.20 M |
| 05/24/2021 | Q1 2021 | N/A | -$33.99 | N/A | N/A | $2.66 M |
| 03/03/2021 | Q4 2020 | N/A | $2.12 | N/A | N/A | $3.24 M |
Celularity Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 14th, 2025 based offlast year's report dates.
In the previous quarter, Celularity Inc. (:CELUW) reported $-0.87571 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.5 by $0.62429.
The conference call for Celularity Inc.'s latest earnings report can be listened to online.
The conference call transcript for Celularity Inc.'s latest earnings report can be read online.
Celularity Inc. (:CELUW) has a recorded annual revenue of $54.22 M.
Celularity Inc. (:CELUW) has a recorded net income of $-57,892,000.Celularity Inc. has generated $-2.6446 earnings per share over the last four quarters.
Celularity Inc. (:CELUW) has a price-to-earnings ratio of -0.62 and price/earnings-to-growth ratio is 0.13.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED